Tilray Brands (Tilray Brands) Stock Based Compensation : $34.4 Mil (TTM As of Feb. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Tilray Brands Stock Based Compensation?

Tilray Brands's Stock Based Compensation for the three months ended in Feb. 2024 was $8.1 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2024 was $34.4 Mil.

Tilray Brands Stock Based Compensation Historical Data

The historical data trend for Tilray Brands's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Stock Based Compensation Chart

Tilray Brands Annual Data

Trend

Aug14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Stock Based Compensation

Get a 7-Day Free Trial

21.95

18.08

17.35

35.99

39.60

Tilray Brands Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Stock Based Compensation	Get a 7-Day Free Trial															9.63	9.83	8.26	8.20	8.06

Tilray Brands Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $34.4 Mil.

Tilray Brands Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Tilray Brands (Tilray Brands) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (NAS:TLRY) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

2HQ:Germany 2HQ:Germany 2HQ:Germany 2HQ:Germany TLRY:Canada TLRY:Austria

Address

265 Talbot Street West, Leamington, ON, CAN, N8H 5L4

Website

https://www.tilray.com

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.

Executives

Denise M Faltischek	officer: Chief Strategy Officer	C/O THE HAIN CELESTIAL GROUP, INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Mitchell Gendel	officer: Global General Counsel	EMERALD HOLDING, INC., 100 BROADWAY, 14TH FLOOR, NEW YORK NY 10005
Irwin D Simon	director, officer: President & CEO	C/O THE HAIN CELESTIAL GROUP INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Carl A Merton	officer: Chief Financial Officer	C/O TILRAY, INC., 745 FIFTH AVENUE, SUITE 1602, NEW YORK NY 10151
Brendan Kennedy	director	1920 EASTLAKE AVENUE E., SEATTLE WA 98105
James R. Meiers	officer: Head of Canada	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David G. Hopkinson	director	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Thomas P. Looney	director	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Johann Michael Herhalt	director	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Jodi L. Butts	director	C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David F Clanachan	director	TIM HORTONS INC., 874 SINCLAIR ROAD, OAKVILLE A6 L6K 2Y1
Renah Persofsky	director	55 PRINCE ARTHUR AVENUE, #604, TORONTO A6 M5R 1B3
Jon Edward Levin	officer: Chief Operating Officer	2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Michael C. Kruteck	officer: Chief Financial Officer	2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Rebekah Dopp	director	444 LENOX AVENUE, SOUTH ORANGE NJ 07079